Skip to main content
. Author manuscript; available in PMC: 2019 Jun 27.
Published in final edited form as: J Allergy Clin Immunol. 2014 Dec 18;135(5):1199–206.e1-11. doi: 10.1016/j.jaci.2014.10.042

Table E4. Absolute risks for persistence of ARbp up to age 16 years in relation to the number of IgE-reactive PR-10 proteins at 4 and 8 years of age, respectively.

Transient Persistent
No. No. Percent No. Percent 95% CI
No. of PR-10 proteins at age 4 y (n = 19)†
    0 5 5 100 0     0      0-52.2
    Bet v 1 only 0 —   — —   —
    Bet v 1 and 1-3* 6 2   33.3 4   66.7 22.3-95.7
    Bet v 1 and ≥4 8 0     0 8 100 63.1-100
No. of PR-10 proteins at age 8 y (n = 66)‡
    0 13 7   53.9 6   46.2 19.2-74.9
    Bet v 1 only 3 0     0 3 100 29.2-100
    Bet v 1 and 1-4* 17 4   23.5 13   76.5 50.1-93.2
    Bet v 1 and ≥5 33 3     9.1 30   90.9 75.7-98.1
*

Median number of IgE-reactive proteins or less.

†

ARbp at age 4 years.

‡

ARbp at age 8 years but not age 4 years.